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ABSTRACT
We have identified strong topoisomerase sites (STS)
for Mycobacteruim smegmatis topoisomerase I in
double-stranded DNA context using electrophoretic
mobility shift assay of enzyme–DNA covalent
complexes. Mg2+, an essential component for DNA
relaxation activity of the enzyme, is not required for
binding to DNA. The enzyme makes single-stranded
nicks, with transient covalent interaction at the 5′-end
of the broken DNA strand, a characteristic akin to
prokaryotic topoisomerases. More importantly, the
enzyme binds to duplex DNA having a preferred site
with high affinity, a property similar to the eukaryotic
type I topoisomerases. The preferred cleavage site is
mapped on a 65 bp duplex DNA and found to be
CG/TCTT. Thus, the enzyme resembles other prokaryotic
type I topoisomerases in mechanistics of the reaction,
but is similar to eukaryotic enzymes in DNA recognition
properties.
INTRODUCTION
DNA topoisomerases are ubiquitous enzymes catalyzing the
interconversion of topological forms of DNA (1). The enzymes
transiently break the DNA backbone bonds and allow the passage
of the intact DNA through these enzyme-operated DNA gates. As
a consequence of these reactions, they play a major role in various
biological processes involving DNA, such as replication (2),
transcription (3), recombination (3) and chromosome dynamics (4).
Chromosomal superhelical density in prokaryotes is homeostatically
maintained as a result of cumulative action of topoisomerase I and
DNA gyrase (5). Type I topoisomerases relax supercoiled DNA
by concerted reactions involving single-strand cleavage and
religation of the DNA backbone bonds after the passage of the
other strand (1). During this process the enzyme becomes
covalently linked to the transiently nicked DNA, and it is possible
to identify the preferential cleavage site of topoisomerases by
irreversible arrest of the covalent intermediate (6).
Generally, topoisomerases do not exhibit very high sequence
specificity, unlike restriction enzymes, repressors and transcriptional
activators. Yet, a few of them show some degree of site specificity
while others show some sequence preference. The sequence
specificities for gyrase (7) and eukaryotic type I (8,9) and type II
(10) topoisomerases have been subjected to extensive studies. In the
case of Escherichia coli DNA gyrase, a 140 base pair (bp) DNA
segment is wrapped around the enzyme in the enzyme–DNA
complex (11). A strong gyrase binding site (SGS) has been located
within the tet gene at position 990 on pBR322 DNA (12).
Bacteriophage Mu DNA has a SGS located towards the center of the
genome which is indispensable for the optimal replicative trans-
position (13). Tetrahymena DNA topoisomerase I preferentially
cleaves a hexadecameric sequence present in the DNaseI-hyper-
sensitive regions in the non-transcribed spacer of the rDNA (14).
In contrast, vaccinia virus DNA topoisomerase I recognizes short
DNA sequences and exhibits a strong sequence specificity. The
enzyme cleaves after the pentameric sequence motif (C/T)CCTT
(15). A variety of topoisomerase inhibitors inhibit the enzyme
activity by arresting enzyme–DNA covalent reaction intermediates.
These topoisomerase poisons influence the sequence-specific
cleavage by topoisomerases (16,17,18).
The type I topoisomerases from prokaryotes are known to
prefer single-stranded regions in DNA (6). Initial studies with
E.coli and Micrococcus luteus topoisomerase I showed that
cleavage of single-stranded DNA substrates occurs preferentially
at the sequence 5′-CXXX-3′. In the case of the E.coli enzyme,
G residues are not found at position –1 in 80% of the cleavage
sites studied (19). However, this sequence requirement is not
sufficient to account for the observed non-random distribution of
the cleavage sites. The cleavage sites were also mapped on
single-stranded oligonucleotides (20) or double-stranded DNA
with a nick (21) or a loop (22). Site-specific interaction of the
E.coli topoisomerase III has been studied in some detail (23). The
enzyme binds with high affinity to a single-stranded DNA
substrate with a strong cleavage site (CT*T) and can cleave a
substrate as small as a heptamer.
Here we report the identification of preferred cleavage sites for
Mycobacterium smegmatis topoisomerase I. We have designed a
new strategy for determining the preferred cleavage site for the
enzyme on duplex DNA fragments. To our surprise, we find that
the enzyme binds to double-stranded DNA with high affinity, a
characteristic feature of eukaryotic type I topoisomerases.
MATERIALS AND METHODS
Enzymes and nucleic acids
Topoisomerase I was purified to apparent homogeneity from
M.smegmatis SN2 cells as described (to be published elsewhere).
In brief, the cell free extract was treated with 1% polyethyl-
eneimine and the supernatant was purified through phospho-
cellulose, SP-Sepharose and Q-Sepharose columns. The enzyme
*To whom correspondence should be addressed. Tel: +91 80 3092598; Fax: +91 80 3341683; Email: vraj@cge.iisc.ernet.in
 by guest on Novem
ber 29, 2010
n
a
r.o
xfordjournals.org
D
ow
nloaded from
 
1669
Nucleic Acids Research, 1994, Vol. 22, No. 1Nucleic Acids Research, 1998, Vol. 26, No. 7 1669
Table 1. Sequences of oligonucleotides used in this study
has an apparent molecular mass of 110 kDa. One unit of enzyme
catalyses 50% conversion of 500 ng of supercoiled pUC19 DNA
into different relaxed topoisomers at 37C in 30 min under standard
assay conditions. The protein concentration was estimated by the
method of Bradford (24), using crystalline bovine serum albumin
as standard.
Plasmid DNA was purified by the standard procedures (25).
Restriction enzymes were purchased from Boehringer Mannheim
and New England Biolabs and used according to the manufacturer’s
specifications. Klenow fragment of E.coli DNA polymerase I,
acrylamide and other electrophoresis reagents were obtained
from Gibco-BRL. NAP10 gel filtration columns were purchased
from Pharmacia. Radioactive nucleotides were obtained from
Amersham International, UK.
Labeling of DNA fragments
DNA fragments generated after different restriction enzyme
digestions were end-filled with either [α-32P]dATP or
[α-32P]dCTP (5000 Ci/mmol) and other cold dNTPs, using
Klenow fragment of E.coli DNA polymerase I. Radiolabeled
fragments were purified using Sephadex G-25 spin columns.
Radiolabeled nucleotide (10 µCi) was used per reaction and the
specific activity of labeling was ∼107 c.p.m./µg of DNA used.
For purification of the individual fragments, the labeled
fragments were separated on native polyacrylamide gels. The gel
pieces containing the required fragments were excised and DNA
was eluted into 10 mM Tris–HCl pH 8.0 and 1 mM EDTA by
constant shaking at 37C. The eluant was passed through NAP10
gel filtration columns according to suppliers’ specifications. NAP10
column fractions containing the radioactivity were precipitated with
ethanol, using glycogen as carrier, and re-dissolved in sterile water.
Electrophoretic mobility shift assays (EMSAs)
Reaction mixtures (20 µl) contained 20 mM Tris–HCl pH 8.0,
1 mM EDTA, 20 mM NaCl, radiolabeled DNA fragments
(25 fmol, 10 000 c.p.m) and topoisomerase I (0.1–1 pmol). The
reactions were incubated at 37C for 10 min and then arrested
with 25 mM NaOH. Incubations were continued for another
5 min and then the reaction mixtures were neutralized using
25 mM HCl and 25 mM Tris–HCl pH 8.0. The complexes were
treated with 50 µg/ml proteinase K in the presence of 1% SDS and
50 mM EDTA for 3 h at 37C, wherever indicated. The products
were separated through a 10% polyacrylamide gel (29:0.8) using
0.5× TBE (25) as the running buffer. The gels were electro-
phoresed at 100 V at room temperature, dried and then subjected
to autoradiography.
The non-covalent binding of the enzyme to DNA was also
assessed by EMSA to determine the Kd value. DNA (32mer
duplex DNA with the cleavage site) was incubated with varying
amounts of the enzyme in the reaction buffer for 10 min on ice and
the samples were analyzed on 5% native polyacrylamide gels at
4C. The amount of radioactivity in the free and bound fractions
was determined by liquid scintillation counting. This 32 bp
oligonucleotide and a 30 bp oligonucleotide were used as specific
and non-specific competitors respectively, for the non-covalent
complex formation. The sequences of the oligonucleotides used
in the present study are presented in Table 1.
Determination of cleavage sites
The 65 bp HinfI fragment of pUC19 (Fig. 5C) was differentially
labeled on the top strand with [α-32P]dCTP (depending on the
identity of N in the HinfI site, GANTC). Differential 5′-end
labeling of the bottom strand was carried out as follows. The 65 bp
fragment was labeled with [γ-32P]ATP and T4 polynucleotide
kinase followed by digestion with HaeIII which resulted in the
removal of the label from the 5′-end of the top strand. Reaction
mixtures (20 µl) containing 20 mM Tris–HCl, 20 mM NaCl, 5 mM
MgCl2 and radiolabeled DNA fragment were incubated with
topoisomerase I at 4 or 37C for 10 min. The covalent complex
was arrested and the protein was removed from the complex with
proteinase K treatment. Samples were extracted with phenol/
chloroform and precipitated with ethanol in the presence of 5 µg
yeast tRNA used as a carrier. The precipitated DNA samples were
suspended in 10 µl of formamide loading dye and heat denatured
for 5 min at 90C. Sequencing of the DNA fragment by chemical
method was according to Maxam and Gilbert (26). The reaction
products were re-dissolved in 50% formamide, 10 mM EDTA,
0.025% xylene cyanol and 0.025% bromophenol blue, heat
denatured for 5 min at 90C and analyzed on 15% poly-
acrylamide–8 M urea gels. The gels were dried and subjected to
autoradiography.
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RESULTS
Identification of DNA fragments having preferred cleavage
site(s)
A new method was used to identify strong topoisomerase sites
(STS) on duplex DNA substrates. Figure 1A shows the scheme
of the experiment. The rationale of the approach is based on the
conjecture that the enzyme could interact with double-stranded
DNA as it would normally encounter a duplex DNA in vivo. If the
enzyme binds tightly at a site on the duplex DNA fragment, the
complex could be arrested as an enzyme–DNA reaction inter-
mediate. Such covalent complexes could be detected as slower
moving bands on a native polyacrylamide gel. An example of
such an experiment is shown in Figure 1B. DNA fragments
generated by HinfI digestion of pUC19 were radiolabeled and
used as substrates for complex formation in the absence of Mg2+
(see later section). When the DNA–protein covalent complex was
arrested with NaOH, a few of the fragments showed retarded
electrophoretic mobility including the two smallest fragments
(Fig. 1B, lane 3). Proteinase K digestion of the reaction products
abolishes the retarded mobility of the fragments (Fig. 1B, lane 4).
Even in the presence of larger DNA fragments (214 and 396 bp),
covalent complexes are seen with the 75 and 65 bp fragments,
indicating sequence preference of the enzyme. Specific interac-
tion of the enzyme at preferred sites on duplex DNA was
confirmed by carrying out the assay with fragments generated
with other restriction enzymes (data not shown). The method
seems to be a convenient approach to identify STS on double-
stranded DNA fragments.
EMSA with individual fragments having STS
The purified 65 bp and the 75 bp HinfI fragments were used for
further analysis. The fragments were incubated with different
concentrations of enzyme (Fig. 2). Increased amounts of
complexes were formed with the increase in enzyme concentration
(Fig. 2, lanes 4 and 5, and 10 and 11). When the NaOH treatment
was omitted, no complex was observed (Fig. 2, lanes 3 and 9) as
topoisomerase I cannot form a stable non-covalent complex
under the conditions of the assay and electrophoresis. The higher
amount of radioactivity in the complex of the 65 bp fragment
indicates that it is a better substrate than the 75 bp fragment (Fig. 2,
compare lanes 4 and 10). Proteinase K treatment abolishes the
complexes (Fig. 2, lanes 6 and 12), demonstrating that the
observed complexes were indeed protein mediated.
The ability of M.smegmatis topoisomerase I to form the covalent
complex with the 65 bp fragment was compared with different DNA
fragments. A 214 bp fragment (pUC19 digested with HinfI), a
114 bp fragment (pUC19 digested with HinfI and DraI) and a 30 bp
fragment (pUC19 digested with TaqI) did not form any detectable
covalent complex with M.smegmatis topoisomerase I (not shown
and Fig. 4, lane 9). Thus, it seems that not just any double-stranded
DNA fragment is a substrate for the enzyme.
Mg2+ is not required for DNA binding and cleavage
The covalent trapping experiments described above were carried
out in the absence of Mg2+. This was necessary, as the presence
of 5 mM Mg2+ in the reaction (concentration used for relaxation
assay) resulted in lower yields of trapped complexes. The enzyme
can efficiently bind and cleave double-stranded DNA in the
Figure 1. Method for identification of ‘strong topoisomerase I site(s)’.
(A) Scheme of the experiment. (B) 10% native PAGE to resolve covalent
complexes. End-filled HinfI digested pUC19 fragments (50 000 c.p.m., 5 ng)
(lane 1) were incubated with 100 fmol of purified topoisomerase I (lane 2).
Covalent complexes were not detected without alkali treatment. The largest
fragment, however, shows retardation, possibly due to specific and non-specific
interactions. Covalent complexes were trapped with NaOH (lane 3). Proteinase K
treatment of the covalent complexes (lane 4) greatly abolishes the retardation of the
complex. Arrows indicate the covalent complexes from the 65 and 75 bp
fragments.
A
B
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Figure 2. Electrophoretic mobility shift assay with the individual fragments.
The end-labeled 65 bp (lanes 1–6) and 75 bp (lanes 7–12) DNA fragments were
used as substrates (10 000 c.p.m., 25 fmol) in the absence of Mg2+. Lanes 1, 2,
7 and 8, no topoisomerase I; lanes 4 and 10, 1 pmol, and lanes 3, 5, 6, 9, 11 and
12, 2 pmol of topoisomerase I. The samples were run in 10% native PAGE as
described in Materials and Methods. Proteinase K treatment (lanes 6 and 12)
results in abolishing the covalent complex.
absence of Mg2+ (Fig. 3, lane 2). The amount of covalent complex
decreased with the increase in Mg2+ ion concentration (Fig. 3,
lanes 3–5). However, it should be noted here that there is an
absolute requirement for Mg2+ ions for the DNA relaxation
activity of the enzyme (27). These results indicate that Mg2+ is
not required for DNA binding and cleavage, yet it is required at
a subsequent step of catalysis. A noteworthy point is that
eukaryotic type I topoisomerases do not require Mg2+ ions for
their activity, but the metal ion can activate the religation (15) or
cleavage step (28) of the enzyme. Mg2+ is also known to shift the
enzyme from a processive to a distributive mode of catalysis (29).
The decrease in the amount of covalent complex at 10 mM Mg2+
could be due to an ionic effect contributing to reduced interaction
between protein and DNA. At this concentration of Mg2+, DNA
relaxation activity is also inhibited (not shown). The decrease in
the covalent complex at higher concentrations of Mg2+ could also
be due to an ionic effect resulting in reduced interaction.
Examples of other DNA–protein interaction studies indicate that
binding of protein to their specific sites may or may not be
metal-ion-dependent. This aspect can best be illustrated by taking
the examples of restriction endonucleases EcoRI and EcoRV.
EcoRI can bind to DNA in the absence of Mg2+ but requires its
presence for the cleavage at the specific site (30). In contrast,
binding of Mg2+ to the restriction endonuclease EcoRV is a
pre-requisite for the enzyme to bind to its cognate site. In the latter
case, Mg2+ is also required for cleavage (31,32). In a recent study,
E.coli topoisomerase I was shown to have bound Mg2+ ions in
two different pockets of the enzyme. The occupancy at both the
sites is required for the DNA relaxation activity of the enzyme
(33). Additional experiments would delineate the precise role of
Mg2+ in M.smegmatis topoisomerase I mediated reactions.
Competition assay with different DNA substrates
Prokaryotic type I topoisomerases are known to prefer single-
stranded DNA or single-stranded regions in the double helical
DNA as efficient substrates for the enzyme activity (34). Such
substrates could efficiently compete with the 65 bp fragment for
complex formation. When M13 single-stranded DNA (Fig. 4,
lane 3) and supercoiled pUC19 DNA (Fig 4, lane 10) were used
as competitors, no complex was observed with the 65 bp
fragment. When single-stranded oligonucleotides of different
Figure 3. Effect of Mg2+ on DNA binding and cleavage. End-labeled 65 bp
DNA fragment (lane 1) was incubated with 2 pmol of topoisomerase I and the
complex was arrested with NaOH (lanes 2–5) in the presence of 2.5 mM (lane 3),
5 mM (lane 4) and 10 mM (lane 5) Mg2+. Other details are as described in
Materials and Methods.
Figure 4. Competition assay with different single- and double-stranded DNA
substrates. End-labeled 65 bp DNA fragment was used as the substrate. Lane 1,
no topoisomerase; in all the other lanes 1 pmol of topoisomerase I was used and
the complex was arrested with NaOH. Lane 2, no competitor; lane 3,
single-stranded M13 DNA; lanes 4–6, 15 base, 26 base and 30 base
oligonucleotides, respectively; lane 7, unlabeled 75 bp DNA fragment; lane 8,
relaxed pUC19 DNA; lane 9, unlabeled 114 bp DNA fragment; lane 10,
supercoiled pUC19 DNA. All the competitors were taken in 25-fold molar excess.
lengths (15, 27 and 30mer) were used, the complex formation
with the 65 bp fragment remained unaffected (Fig. 4, lanes 4–6).
Thus, any single-stranded DNA is not a good substrate for the
enzyme. Escherichia coli topoisomerase I is known to bind short
single-stranded oligonucleotides. Even an 8mer oligonucleotide
serves as a good substrate to the enzyme (20). Thus, the absence
of competition with larger oligonucleotides (27 and 30mer) in our
study is unlikely to be due to inadequate length. Amongst the
other DNA substrates used as competitors, the 75 bp DNA
fragment and the relaxed pUC19 DNA were found to compete
partially with the 65 bp fragment (Fig. 4, lanes 7 and 8) under the
present experimental conditions. A 114 bp fragment cannot
inhibit the complex formation with the 65 bp fragment (Fig. 4,
lane 9). Similarly, 30 and 214 bp DNA fragments were also
unable to compete with the 65mer for covalent complex
formation (not shown). These results confirm the point that the
M.smegmatis topoisomerase I does not bind to any single- or
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Figure 5. Localization and mapping of the cleavage site(s). (A) Autoradiogram of the SDS–PAGE. 1 and 2 pmol of topoisomerase I were used for complex formation
(lanes 1 and 2). Position of a 116 kDa molecular weight marker is indicated by arrow. The radiolabeled protein band was not observed when the reaction was carried
out under the following conditions: omission of alkali treatment, omission of enzyme or incubation of DNA with BSA and alkali. (B) Mapping of the cleavage site(s)
on the 65 bp fragment. Differentially labeled 65 bp fragment (labeled at the 3′-end of the top strand) was used as the substrate. A mixture of chemical cleavage reactions
(G, A>G, C+T) and G sequencing lanes are indicated. 65 bp DNA (1 pmol, 5 × 105 c.p.m.) was incubated with 2 pmol of topoisomerase I in indicated lanes, at 4C
(lane 4) or 37C (lanes 3 and 5). Heat-denatured enzyme was used in lane 3. DNA was treated with only NaOH (lane 6), or the NaOH treatment was omitted (lane 7, also
serves as a proteinase K control). DNA was incubated with protein without trapping of the complex (lane 2). (C) Sequence of 65 bp HinfI fragment of pUC19 DNA.
The arrows represent the position and extent of cleavage.
(C)
double-stranded DNA and exhibits sequence specificity for
efficient binding.
Localization of the cleavage site(s) and characterization of
covalent intermediate
The above experiments demonstrate that the 65 bp DNA
fragment contains strong topoisomerase site(s). However, it does
not indicate the location of the cleavage site(s) to a particular
strand. The following set of experiments were carried out to
determine the STS-containing strand. The 65 bp fragment labeled
at either, or both, ends showed complex formation. Further HaeIII
digestion of the 65 bp fragment (labeled by end filling) results in
removal of the label at the 3′-end of the bottom strand while the
top strand retains the label. Detection of cleavage products in a
denaturing polyacrylamide gel electrophoresis (PAGE) from
such a fragment is an indication of the presence of STS in the top
strand (data not shown). In a reverse experiment, cleavage
products could not be detected when 5′-end labeled fragments
digested with HaeIII were used, indicating the absence of STS on
the lower strand. The presence of STS on the top strand was
confirmed by the differential labeling of the top strand of the 65 bp
fragment with [α-32P]dCTP as described in Materials and
Methods. The uniquely labeled 65 bp fragment was incubated
with M.smegmatis topoisomerase I, the DNA–protein complex
was trapped using NaOH and the samples were analyzed on 1%
SDS–7.5% PAGE (35). The autoradiograph of such a gel showed
that the radioactivity has been transferred to the protein (Fig. 5A).
These results demonstrate that (i) the top strand of the fragment
has specific topoisomerase I cleavage site(s) and (ii) as label is
present at the 3′-end of the DNA, protein–DNA covalent linkage
must be via the 5′ phosphate group at the nick.
Mapping of the cleavage site(s)
The positions of cleavage site(s) were mapped by comparing the
mobility of the cleaved fragment(s) with a sequencing ladder
produced by chemical cleavage of the 65 bp fragment. The 65 bp
fragment, labeled at the top strand, was incubated with the
enzyme on ice or at 37C respectively (Fig. 5B, lanes 4 and 5).
Specific cleavage products were observed with the active enzyme
incubated at 37C (Fig. 5B, lane 5). Three sites of varied
intensities were detected. The chemical cleavage yields fragments
with 3′ phosphates while topoisomerase I cleavage products end
with 3′-OH. This is taken into consideration while mapping the
cleavage positions. Two major cleavage sites map after the
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Figure 6. Competition assay with duplex oligonucleotides. Non-covalent
complexes of topoisomerase I (10 fmol) and a labeled 32 bp specific
oligonucleotide were resolved in a native PAGE (Materials and Methods) to
obtain ∼50% complex formation. The competition with specific (square) and
non-specific (triangle) duplex oligonucleotides (Table 1) were carried out. The
amount of complex was estimated by counting radioactivity in each lane using
a liquid scintillation counter.
trinucleotide CTT (Fig. 5C). Experiments with the uniquely
labeled bottom strand did not release any cleavage products
indicating the absence of preferred sites.
High affinity binding of M.smegmatis topoisomerase I to
duplex DNA
The competition experiments described earlier reflect high
affinity of the enzyme for duplex DNA having STS. EMSA was
employed to assess the binding of the protein to DNA and to
determine the specificity of the interaction. Formation of
non-covalent complexes (not shown) of the enzyme with a 32 bp
duplex oligonucleotide having STS enabled us to make an estimate
of the equilibrium dissociation constant for the M.smegmatis
topoisomerase I. The duplex DNA was incubated with increasing
amounts of the enzyme. The concentration of the enzyme
required for 50% of the duplex oligonucleotide to form the
complex was taken as the Kd value. The value of 1–5 × 10–9 M
is comparable to the affinity of many other site-specific DNA
binding proteins, such as Arc and Trp repressors (36,37). The
value is also comparable to the equilibrium dissociation constant
of DNA gyrase of E.coli (38) and to that of Tetrahymena
topoisomerase I (17), to their respective preferred sites. A
competition assay was carried out with specific and non-specific
duplex oligonucleotides (Table 1) to further assess the affinity of
the enzyme. For this purpose, the topoisomerase and labeled
32mer duplex (specific) DNA were incubated to obtain 50%
complex formation as in the case of Kd measurements. The ability
of the specific and non-specific oligonucleotides to chase the
non-covalent protein–DNA complex is shown in Figure 6. The
absence of competition even at 1000-fold excess of the non-specific
oligonucleotide also reflects the specific, high affinity interaction
of the enzyme with DNA.
DISCUSSION
In this manuscript, we describe the site specific binding and
cleavage reactions of topoisomerase I from M.smegmatis. We
demonstrate that the enzyme binds to double-stranded DNA at
regions having strong topoisomerase I sites with high affinity. The
cleavage site within the binding region is determined, and is
surprisingly similar to the cleavage sites of some of the well
characterized eukaryotic topoisomerases. We also demonstrate
that not just any double-stranded DNA is a good substrate.
Further, in spite of binding tightly to the double-stranded DNA,
the enzyme makes only single-stranded nicks with covalent
attachment to the 5′-end at the nick.
The earlier method employed to identify the cleavage sites for
different type I topoisomerases was to analyze the cleavage
product obtained from an end-labeled single-stranded DNA
fragment after trapping of the covalent complex. The cleavage
sites of E.coli and M.luteus topoisomerase I were mapped on
single-stranded DNA fragments by Tse et al. (19). Archaebacterial
reverse gyrase (39) and E.coli topoisomerase III (23) cleavage
sites have also been mapped on single-stranded DNA substrates.
This approach while successful, produces a large number of
cleavage products. This is expected as type I topoisomerases from
prokaryotes are known to prefer single-stranded DNA for their
binding and cleavage. Analyses of many cleavage sites of the
enzymes do not reflect a high degree of sequence specificity. A
notable exception is observed in the case of the E.coli topoisomerase
III cleavage site, wherein a highly preferred site is mapped to a
sequence CTT (23). The approach we employed to identify the
preferred site is rather novel and developed on the following
premise. In most circumstances, the enzyme would normally
encounter DNA in double-stranded form, although single-
stranded regions in superhelical DNA would also be available for
its interaction. Thus, when the enzyme encounters a highly
preferred site in double-stranded DNA, it should have the
potential to bind tightly at the sequence to carry out the breakage
and reunion reactions. The method employed here is easy to
perform and only strong topoisomerase sites in double-stranded
DNA context would be identified.
Analyses of the cleavage sites of different topoisomerases show
considerable similarity in the cleavage pattern of the mycobacterial
enzyme to that of topoisomerase III from E.coli (23) and
topoisomerase I from Tetrahymena (14) and vaccinia virus (15).
The cleavage is next to sequence CTT for topoisomerase I from
M.smegmatis, which is very similar to that of vaccinia type I
enzyme. A point to be noted here is that topoisomerase III from
E.coli falls into the type 1A category making 5′-end covalent
contacts, while vaccinia and Tetrahymena enzymes come under
type 1B group, making 3′ covalent complexes during the
intermediate stage of catalysis (40). The results presented in this
paper, show that M.smegmatis topoisomerase I makes a 5′-end
covalent contact similar to topoisomerase III of E.coli and hence
belongs to the 1A group.
The site-specific, high-affinity binding of topoisomerase I from
M.smegmatis to double-stranded DNA is rather unexpected and
raises additional questions. Clearly, the ability to bind double-
stranded DNA efficiently and then make specific single-stranded
nicks is of physiological relevance. It is also conceivable that unlike
other prokaryotic type I enzymes, the enzyme shows preference for
double-stranded DNA like the eukaryotic counterparts, as
organisms belonging to the actinomycetes are considered to be
evolved prokaryotes (41,42).
We propose the following model to explain the action of
topoisomerase I from M.smegmatis. Initially the enzyme would
bind to any region of DNA in a random fashion. This binding
could be considered as low-affinity binding. Once bound to DNA,
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the enzyme could slide or track along the DNA as in the case of
other site-specific DNA binding proteins such as repressors, RNA
polymerase, restriction endonucleases, etc. This linear diffusion
along the DNA is very likely to be random and could be in either
direction. Encounter of STS by the enzyme while tracking would
result in high-affinity binding. Thus, high-affinity binding at the
preferred cleavage site would be the prerequisite for stable
interaction of the protein with the DNA before cleavage of the
duplex DNA to generate molecular gates.
In this report, we have addressed mainly the unusual aspects of
the interaction of a new prokaryotic type I topoisomerase with
DNA. A detailed analysis of the various steps of catalysis, strand
passage, religation, etc. need to be carried out using variety of
natural and synthetic DNA substrates to further delineate the
molecular mechanisms of enzyme action. Of particular interest
would be the study of inhibition of cleavage and/or relaxation
activity by oligonucleotides having the specific cleavage sites. In
the virtual absence of known inhibitors of prokaryotic type I
topoisomerases, this approach would provide an opportunity for
rational design of ligands targeted to this class of enzymes. This
aspect gains further credence as mycobacterial infections are
rampant world wide and there is an urgent need to develop new
therapeutics due to the increasing emergence of multiple drug
resistant clinical strains of Mycobacterium tuberculosis (43).
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